Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MADD Antikörper (C-Term)

MADD Reaktivität: Human, Maus, Ratte WB, IF, EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN500216
  • Target Alle MADD Antikörper anzeigen
    MADD (MAP-Kinase Activating Death Domain (MADD))
    Bindungsspezifität
    • 15
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 31
    • 22
    • 14
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 38
    Kaninchen
    Klonalität
    • 38
    Polyklonal
    Konjugat
    • 17
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MADD Antikörper ist unkonjugiert
    Applikation
    • 15
    • 14
    • 13
    • 9
    • 6
    • 6
    • 5
    • 4
    • 4
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
    Spezifität
    This antibody detects MADD at C-term.
    Kreuzreaktivität (Details)
    Species reactivity (tested):Human, mouse, rat
    Aufreinigung
    DEAE purified
    Immunogen
    MADD antibody was raised against a peptide corresponding to amino acids near the carboxy terminus of human MADD.
    Isotyp
    IgG
    Top Product
    Discover our top product MADD Primärantikörper
  • Applikationshinweise
    ELISA. Western blot: 1: 250 - 1: 500 dilution, 200 to 220 kDa bands should be detected. Immunocytochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS containing 0.02 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C for longer.
  • Target
    MADD (MAP-Kinase Activating Death Domain (MADD))
    Andere Bezeichnung
    MADD (MADD Produkte)
    Synonyme
    MADD antikoerper, MGC145371 antikoerper, DENN antikoerper, IG20 antikoerper, RAB3GEP antikoerper, 9630059K23Rik antikoerper, MAP kinase activating death domain antikoerper, MAP-kinase activating death domain antikoerper, MADD antikoerper, madd antikoerper, Madd antikoerper
    Hintergrund
    MAP kinase-activating death domain protein (MADD) was initially identified as the type 1 tumor necrosis factor receptor (TNFR1) associated protein though their death domains. Overexpression of MADD activates MAP kinases ERK and JNK and induces the phosphorylation of cytosolic phospholipase A2. MADD shares 98 % identity with DENN (for differentially expressed in neoplastic vs. normal cells), which was recently identified as a substrate for c-jun N-terminal kinase 3 (JNK3). MADD has greater than 94 % overall identity to a GDP/GTP exchange protein Rab3-GEP. MADD is 87 % identical to KIAA0358, a brain protein of unknown function. Identification of MADD as a component of the TNFR1 signaling complex and the similarity between MADD and Rab3-GEP provides a connection between TNFR1 activation and downstream MAP kinase activity through a guanine-nucleotide exchange protein.Synonyms: DENN, IG20, MAP kinase-activating death domain protein, RAB3GEP, Rab3 GDP/GTP exchange factor
    Gen-ID
    8567
    UniProt
    Q8WXG6
    Pathways
    Caspase Kaskade in der Apoptose
Sie sind hier:
Kundenservice